SCHEDULE 13G/A: Adage Capital Management Discloses 9.79% Stake in Shattuck Labs
Beneficial Ownership Disclosure
Adage Capital Management, L.P. and its principals, Robert Atchinson and Phillip Gross, have disclosed a significant beneficial ownership of 9.79% in Shattuck Labs, Inc. as of December 31, 2024.
Summary
- Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, collectively reported beneficial ownership of 4,675,000 shares of Shattuck Labs, Inc. Common Stock.
- This ownership represents 9.79% of Shattuck Labs' outstanding Common Stock.
- The percentage is calculated based on 47,739,708 shares of Common Stock outstanding as of November 1, 2024, as reported in Shattuck Labs' Quarterly Report on Form 10-Q for the period ended September 30, 2024.
- The reporting persons, including Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross, share both voting and dispositive power over these 4,675,000 shares.
- The filing is an Amendment No. 1 to Schedule 13G, indicating an update to a previously filed statement.
- Adage Capital Partners GP, L.L.C. is noted as no longer being a beneficial owner of securities held by ACP, despite the filing being submitted under its CIK number for EDGAR system access.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive as a significant institutional stake can be viewed favorably by the market, indicating confidence in the company. However, the document itself is a factual disclosure and does not contain performance or operational updates.
Positives
- The disclosure of a significant 9.79% stake by a reputable investment firm like Adage Capital Management can signal institutional confidence in Shattuck Labs, Inc.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
This filing indicates a significant institutional investment in Shattuck Labs, Inc., a biotechnology company. Such disclosures are common in the biotech sector, where institutional investors often take substantial positions in companies with promising pipelines or technologies.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Beneficial Owner | Adage Capital Partners GP, L.L.C. | NA | NA | Adage Capital Partners GP, L.L.C. is no longer the beneficial owner of securities held by ACP, as stated in the filing. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Adage Capital Management may be perceived positively, potentially boosting investor confidence and attracting further investment.
- Company Management: A large institutional holder like Adage Capital Management may exert influence on corporate strategy and governance, aligning interests with long-term value creation.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2024-11-01 | Date as of which 47,739,708 shares of Common Stock were reported outstanding in Shattuck Labs' Form 10-Q. |
| 2024-11-14 | Date Shattuck Labs filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024. |
| 2024-12-18 | Effective date for structured data requirements applicable to Schedule 13G filings. |
| 2024-12-31 | Date of event which requires the filing of this Schedule 13G statement. |
| 2025-02-12 | Date of signing for the Schedule 13G/A filing. |
Keywords
Shattuck Labs, Adage Capital Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.